Sepsis-Associated Encephalopathy Clinical Trial
Official title:
Role of Semi-automatic MSCT Volumetry in Assessment of Rapidly Progressive Brain Atrophy in Septic ICU Patients.
assessment of brain atrophy associated with septic ICU patients by using MSCT Volumetry
Sepsis is the leading cause of admission to ICU , the number of patients who survive and discharge from ICU has also increased due to technological advances in ICU however quality of life of these patients after ICU discharge is lower than that of healthy people of a similar age, in particular Sepsis associated encephalopathy associated with brain dysfunction. We hypothesized that brain damage including brain volume reduction that ocurre in acute phase of Sepsis using CT scan and there finding " relationship to risk factor and outcome". We compared head CT finding at time of admission with those obtained during the course of the treatment ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05451537 -
Correlation of Formyl Peptide Receptor 1 With Sepsis-related Encephalopathy
|
||
| Completed |
NCT04076826 -
Adjunctive Sedation With Dexmedetomidine for the Prevention of Severe Inflammation and Septic Encephalopathy
|
N/A | |
| Recruiting |
NCT05918705 -
Optic Nerve Sheath Diameter / Eyeball Transverse Diameter Ratio and Prognosis of Sepsis Associated Encephalopathy
|
||
| Recruiting |
NCT04870983 -
The Dynamic Change of MMN in Patients With Sepsis Associated Encephalopathy
|
||
| Recruiting |
NCT04230447 -
Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)
|